Potentiative effects of a kinase II inhibitor (Ys980) on carrageenan-induced oedema in rat hind paw and roles of plasma kininogen.
D015097:3-Mercaptopropionic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001963:Bromelains / Q000494:pharmacology; D002351:Carrageenan; D004357:Drug Synergism; D004487:Edema / Q000139:chemically induced*; D007704:Kininogens / Q000097:blood*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013438:Sulfhydryl Compounds; D053778:Thiazolidines; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D007704:Kininogens; D013438:Sulfhydryl Compounds; D053778:Thiazolidines; C019135:(4R)-3-((2S)-3-mercapto-2-methylpropanoyl)-4- thiazolidinecarboxylic acid; D002351:Carrageenan; D001963:Bromelains; D015097:3-Mercaptopropionic Acid